China Human Microbiome Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Human Microbiome industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Vedanta Biosciences, Inc

    • Second Genome

    • Ferring Pharmaceuticals

    • Ubiome, Inc

    • 4D Pharma PLC

    • EI Du Pont De Nemours and Company

    • Synlogic

    • Seres Therapeutics

    • Evelo Biosciences, Inc

    By Type:

    • Urogenital Tract Human Micobiome

    • Gastrointestinal Tract Human Micobiome

    • Others

    By Application:

    • Therapeutics

    • Diagnostics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Human Microbiome Market Overview 2018-2029

    • 1.1 China Human Microbiome Industry Development Overview

    • 1.2 China Human Microbiome Industry Development History

    • 1.3 China Human Microbiome Industry Market Size (2018-2029)

    • 1.4 China Human Microbiome Market Analysis by Type from Production Side

      • 1.4.1 China Human Microbiome Production Volume, Production Value and Growth Rate of Urogenital Tract Human Micobiome (2018-2029)

      • 1.4.2 China Human Microbiome Production Volume, Production Value and Growth Rate of Gastrointestinal Tract Human Micobiome (2018-2029)

      • 1.4.3 China Human Microbiome Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Human Microbiome Market Analysis by Application from Consumption End

      • 1.5.1 China Human Microbiome Sales Volume, Sales Value and Growth Rate of Therapeutics (2018-2029)

      • 1.5.2 China Human Microbiome Sales Volume, Sales Value and Growth Rate of Diagnostics (2018-2029)

    • 1.6 China Human Microbiome Market Analysis by Region

      • 1.6.1 North China Human Microbiome Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Human Microbiome Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Human Microbiome Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Human Microbiome Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Human Microbiome Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Human Microbiome Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Human Microbiome Market Size and Growth Rate from 2018-2029

    Chapter 2 China Human Microbiome Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Human Microbiome Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Human Microbiome Market Status and Competition Analysis in 2023

      • 2.2.3 China Human Microbiome Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Human Microbiome Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Human Microbiome Industry Development

    Chapter 3 Human MicrobiomeIndustry Chain Analysis

    • 3.1 Human Microbiome Industry Chain

    • 3.2 Human Microbiome Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Human Microbiome Market

    • 3.3 Human Microbiome Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Human Microbiome Market

    Chapter 4 China Human Microbiome Market, by Type

    • 4.1 China Human Microbiome Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Human Microbiome Total Production Volume and Growth Rate from Production Side

    • 4.5 China Human Microbiome Production Volume and Growth Rate, by Type

      • 4.5.1 China Human Microbiome Production Volume and Growth Rate of Urogenital Tract Human Micobiome

      • 4.5.2 China Human Microbiome Production Volume and Growth Rate of Gastrointestinal Tract Human Micobiome

      • 4.5.3 China Human Microbiome Production Volume and Growth Rate of Others

    Chapter 5 China Human Microbiome Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Human Microbiome Total Market Size and Growth Rate from Consumption End

    • 5.5 China Human Microbiome Market Size and Growth Rate, by Application

      • 5.5.1 China Human Microbiome Market Size and Growth Rate of Therapeutics

      • 5.5.2 China Human Microbiome Market Size and Growth Rate of Diagnostics

    Chapter 6 China Human Microbiome Market, by Region

    • 6.1 China Human Microbiome Production Volume and Production Value, by Region

    • 6.2 China Human Microbiome Sales Volume and Sales Value, by Region

    Chapter 7 North China Human Microbiome Market Analysis

    • 7.1 North China Human Microbiome Market, by Type

    • 7.2 North China Human Microbiome Market, by Application

    Chapter 8 Central China Human Microbiome Market Analysis

    • 8.1 Central China Human Microbiome Market, by Type

    • 8.2 Central China Human Microbiome Market, by Application

    Chapter 9 South China Human Microbiome Market Analysis

    • 9.1 South China Human Microbiome Market, by Type

    • 9.2 South China Human Microbiome Market, by Application

    Chapter 10 East China Human Microbiome Market Analysis

    • 10.1 East China Human Microbiome Market, by Type

    • 10.2 East China Human Microbiome Market, by Application

    Chapter 11 Northeast China Human Microbiome Market Analysis

    • 11.1 Northeast China Human Microbiome Market, by Type

    • 11.2 Northeast China Human Microbiome Market, by Application

    Chapter 12 Southwest China Human Microbiome Market Analysis

    • 12.1 Southwest China Human Microbiome Market, by Type

    • 12.2 Southwest China Human Microbiome Market, by Application

    Chapter 13 Northwest China Human Microbiome Market Analysis

    • 13.1 Northwest China Human Microbiome Market, by Type

    • 13.2 Northwest China Human Microbiome Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Vedanta Biosciences, Inc

        • 14.1.1 Vedanta Biosciences, Inc Company Profile

        • 14.1.2 Vedanta Biosciences, Inc Human Microbiome Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Second Genome

        • 14.2.1 Second Genome Company Profile

        • 14.2.2 Second Genome Human Microbiome Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Ferring Pharmaceuticals

        • 14.3.1 Ferring Pharmaceuticals Company Profile

        • 14.3.2 Ferring Pharmaceuticals Human Microbiome Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Ubiome, Inc

        • 14.4.1 Ubiome, Inc Company Profile

        • 14.4.2 Ubiome, Inc Human Microbiome Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 4D Pharma PLC

        • 14.5.1 4D Pharma PLC Company Profile

        • 14.5.2 4D Pharma PLC Human Microbiome Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 EI Du Pont De Nemours and Company

        • 14.6.1 EI Du Pont De Nemours and Company Company Profile

        • 14.6.2 EI Du Pont De Nemours and Company Human Microbiome Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Synlogic

        • 14.7.1 Synlogic Company Profile

        • 14.7.2 Synlogic Human Microbiome Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Seres Therapeutics

        • 14.8.1 Seres Therapeutics Company Profile

        • 14.8.2 Seres Therapeutics Human Microbiome Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Evelo Biosciences, Inc

        • 14.9.1 Evelo Biosciences, Inc Company Profile

        • 14.9.2 Evelo Biosciences, Inc Human Microbiome Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Human Microbiome Industry Research Conclusions

    • 15.2 Human Microbiome Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Human Microbiome Industry Market Size (2018-2029)

    • Figure China Human Microbiome Production Volume, Production Value and Growth Rate of Urogenital Tract Human Micobiome (2018-2029)

    • Figure China Human Microbiome Production Volume, Production Value and Growth Rate of Gastrointestinal Tract Human Micobiome (2018-2029)

    • Figure China Human Microbiome Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Human Microbiome Sales Volume, Sales Value and Growth Rate of Therapeutics (2018-2029)

    • Figure China Human Microbiome Sales Volume, Sales Value and Growth Rate of Diagnostics (2018-2029)

    • Figure North China Human Microbiome Market Size and Growth Rate from 2018-2029

    • Figure Central China Human Microbiome Market Size and Growth Rate from 2018-2029

    • Figure South China Human Microbiome Market Size and Growth Rate from 2018-2029

    • Figure East China Human Microbiome Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Human Microbiome Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Human Microbiome Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Human Microbiome Market Size and Growth Rate from 2018-2029

    • Figure Human Microbiome Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Human Microbiome Market Share by Type in 2018

    • Figure China Human Microbiome Market Share by Type in 2023

    • Figure China Human Microbiome Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Human Microbiome Production Volume and Growth Rate of Urogenital Tract Human Micobiome (2018-2023)

    • Figure China Human Microbiome Production Volume and Growth Rate of Gastrointestinal Tract Human Micobiome (2018-2023)

    • Figure China Human Microbiome Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Human Microbiome Market Share by Application in 2018

    • Figure China Human Microbiome Market Share by Application in 2023

    • Figure China Human Microbiome Total Market Size and Growth Rate from Consumption End

    • Figure China Human Microbiome Market Size and Growth Rate of Therapeutics (2018-2023)

    • Figure China Human Microbiome Market Size and Growth Rate of Diagnostics (2018-2023)

    • Table China Human Microbiome Production Volume by Region (2018-2023)

    • Table China Human Microbiome Production Volume Share by Region (2018-2023)

    • Figure China Human Microbiome Production Volume Share by Region (2018-2023)

    • Table China Human Microbiome Production Value by Region (2018-2023)

    • Table China Human Microbiome Production Value Share by Region (2018-2023)

    • Figure China Human Microbiome Production Value Share by Region (2018-2023)

    • Table China Human Microbiome Sales Volume by Region (2018-2023)

    • Table China Human Microbiome Sales Volume Share by Region (2018-2023)

    • Figure China Human Microbiome Sales Volume Share by Region (2018-2023)

    • Table China Human Microbiome Sales Value by Region (2018-2023)

    • Table China Human Microbiome Sales Value Share by Region (2018-2023)

    • Figure China Human Microbiome Sales Value Share by Region (2018-2023)

    • Table North China Human Microbiome Production Volume by Type (2018-2023)

    • Table North China Human Microbiome Production Volume Share by Type (2018-2023)

    • Figure North China Human Microbiome Production Volume Share by Type (2018-2023)

    • Table North China Human Microbiome Sales Volume by Application (2018-2023)

    • Table North China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Figure North China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Table Central China Human Microbiome Production Volume by Type (2018-2023)

    • Table Central China Human Microbiome Production Volume Share by Type (2018-2023)

    • Figure Central China Human Microbiome Production Volume Share by Type (2018-2023)

    • Table Central China Human Microbiome Sales Volume by Application (2018-2023)

    • Table Central China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Figure Central China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Table South China Human Microbiome Production Volume by Type (2018-2023)

    • Table South China Human Microbiome Production Volume Share by Type (2018-2023)

    • Figure South China Human Microbiome Production Volume Share by Type (2018-2023)

    • Table South China Human Microbiome Sales Volume by Application (2018-2023)

    • Table South China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Figure South China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Table East China Human Microbiome Production Volume by Type (2018-2023)

    • Table East China Human Microbiome Production Volume Share by Type (2018-2023)

    • Figure East China Human Microbiome Production Volume Share by Type (2018-2023)

    • Table East China Human Microbiome Sales Volume by Application (2018-2023)

    • Table East China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Figure East China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Table Northeast China Human Microbiome Production Volume by Type (2018-2023)

    • Table Northeast China Human Microbiome Production Volume Share by Type (2018-2023)

    • Figure Northeast China Human Microbiome Production Volume Share by Type (2018-2023)

    • Table Northeast China Human Microbiome Sales Volume by Application (2018-2023)

    • Table Northeast China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Table Southwest China Human Microbiome Production Volume by Type (2018-2023)

    • Table Southwest China Human Microbiome Production Volume Share by Type (2018-2023)

    • Figure Southwest China Human Microbiome Production Volume Share by Type (2018-2023)

    • Table Southwest China Human Microbiome Sales Volume by Application (2018-2023)

    • Table Southwest China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Table Northwest China Human Microbiome Production Volume by Type (2018-2023)

    • Table Northwest China Human Microbiome Production Volume Share by Type (2018-2023)

    • Figure Northwest China Human Microbiome Production Volume Share by Type (2018-2023)

    • Table Northwest China Human Microbiome Sales Volume by Application (2018-2023)

    • Table Northwest China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Human Microbiome Sales Volume Share by Application (2018-2023)

    • Table Vedanta Biosciences, Inc Company Profile

    • Table Vedanta Biosciences, Inc Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table Second Genome Company Profile

    • Table Second Genome Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table Ferring Pharmaceuticals Company Profile

    • Table Ferring Pharmaceuticals Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table Ubiome, Inc Company Profile

    • Table Ubiome, Inc Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table 4D Pharma PLC Company Profile

    • Table 4D Pharma PLC Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table EI Du Pont De Nemours and Company Company Profile

    • Table EI Du Pont De Nemours and Company Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table Synlogic Company Profile

    • Table Synlogic Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table Seres Therapeutics Company Profile

    • Table Seres Therapeutics Human Microbiome Revenue, Price and Gross (2018-2023)

    • Table Evelo Biosciences, Inc Company Profile

    • Table Evelo Biosciences, Inc Human Microbiome Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.